Professional Documents
Culture Documents
www.elsevier.com/locate/talanta
Short communication
Abstract
Sodium thiosulphate (0.04%w/v) has been used to stabilize ascorbic acid in aqueous medium. The method has been
used to assay ascorbic acid in commercial tablet preparations. It is very accurate, precise and reproducible. It
compares favourably with official titrimetric method. The method is simple and can be adopted for the routine assay
of ascorbic acid in single component tablet formulations. 2000 Elsevier Science B.V. All rights reserved.
Keywords: Ascorbic acid; Stabilizer; Assay
1. Introduction
The use of ascorbic acid (vitamin C) cannot be
over emphasised. Therefore there is a the need to
find a quick and reliable method of assay.
Various methods have been employed for the
analysis of ascorbic acid in pharmaceutical formulations, fruit juices, urine, plasma etc. These include titrations [1,2], high performance liquid
chromatography [3], fluorimetry [4] etc. However,
the use of direct UV for the assay of ascorbic acid
in pharmaceutical formulations has not been easy
due to its instability in aqueous solutions. Recently a UV method of assay of ascorbic acid
based on its stability studies has been reported [5].
The method is very useful for ascorbic acid in the
* Tel.: +233-51-60351; fax: + 233-51-60359.
E-mail address: ustpharm@gh.com (J.K. Kwakye)
0039-9140/00/$ - see front matter 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 0 3 9 - 9 1 4 0 ( 9 9 ) 0 0 2 4 3 - X
198
2. Experimental
2.1. Materials
All absorbances were determined on CECIL
CE800 ultraviolet spectrophotometer using 1 cm
path length.
All formulated ascorbic acid tablets were purchased from the local market.
L-ascorbic acid from BDH chemicals, Poole,
England; sodium sulphite anhydrous AnalaR
BDH; sodium metabisulphite AnalaR BDH;
sodium thiosulphate anhydrous from Hopkin and
Williams, England; vitamin C tablets (100mg
Ascorbic acid) from; EFFAH Pharmaceutical,
Kumasi, Ghana, Batch No. 91R014, G Pharmaceuticals, Accra, Ghana, Batch No. VC44A,
Letap Pharmaceutical, Accra, Ghana, Batch No.
O15109, GIHOC Pharmaceutical, Accra, Ghana,
Batch No. 4040, Bikkai Laboratories, Kumasi,
Ghana, Batch No. 021577.
2.2. Methods
2.2.1. Effect of sodium sulphite and sodium
metabisulphite
Five concentrations of sodium sulphite in water
(0.01%, 0.02%, 0.04%, 0.08% and 0.16%w/v) or
sodium metabisulphite (0.02%, 0.04%, 0.1%,
0.2%, 0.4%w/v) in water were used to prepare
0.001%w/v of Ascorbic acid solutions. The absorbances at 266 nm were recorded at 5 min
intervals over a period of 60 min using the corresponding anti-oxidant blank solution.
2.2.2. Effect of sodium thiosulphate (Na2S2O3)
Three concentrations of sodium thiosulphate in
water (viz. 0.01, 0.02% and 0.04%w/v) were each
used to prepare 0.001%w/v Ascorbic acid solutions. The absorbances at 264 nm were recorded
at 5 min intervals over a period of 60 min for
each preparation using the corresponding sodium
thiosulphate blank solution.
199
4. Conclusions
Sodium thiosulphate at a concentration of
0.04% w/v is a suitable stabilizer for ascorbic acid
in a UV method of assay. The UV method of
assay using a stabilizer is very accurate, precise
and simple. It can be adopted for routine assay of
ascorbic acid tablets and raw materials where
local legislation does not enforce the use of an
official Pharmacopoeia method.
Table 1
Effect of different concentrations of stabilizers on ascorbic acid (0.001%w/v)
Concentration of stabilizers in
water (%w/v)
Sodium sulphite(Na2SO3)
0.01
0.02
0.04
0.08
0.16
7.4
8.8
8.1
8.2
8.7
1.913
1.889
2.538
1.910
3.493
4.3
4.8
4.5
4.2
4.0
2.494
2.385
1.511
0.849
0.581
4.4
4.6
4.6
0.239
0.193
0.000
* Rate of decomposition of ascorbic acid was calculated from absorbance values using five samples of ascorbic acid (0.001%w/v)
in each case over a period of 60 min. The standard deviations ranged from 0.108 to 0.219. Each determination was repeated twice.
Table 2
Assay of ascorbic acid in commercial tablet preparations
Source of tablet preparation UV method
EFFAH
M&G
LETAP
GIHOC
BIKKAI
Titrimetric method
% Purity (n= 8)
% Purity (n =6)
105.4
102.8
100.7
101.2
103.0
0.30
0.29
0.28
0.30
0.29
105.5
102.7
100.8
101.3
103.1
0.11
0.11
0.10
0.11
0.11
200
References
[1] British Pharmacopoeia, vol.1, British Pharmacopoeia
Commission, 1993, p. 54.
[2] British Pharmacopoeia, vol. II, British Pharmacopoeia
Commission, 1993, p.778.
[3] E.S. Wagner, B. Lindley, R.D. Coffin, High performance
liquid chromatographic determination of ascorbic acid in
urine., J. Chromatography 153 (1979) 225.